EP2023902B8
Dpp iv inhibitor formulations
Abstract
This record has no abstract on file.
Term
0.6 yearsleft in the term
Expires 30 April 2027.
- Priority
- Filed
- Granted
- Today
- Expires
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| EP1537880A | Cites | European Patent Office (EPO) |
| WO2004018468A | Cites | World Intellectual Property Organization (WIPO) |
| WO2007017423A | Cites | World Intellectual Property Organization (WIPO) |
| US6548481B1 | Cites | United States of America |
125 members in 37 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 06009201 | European Patent Office (EPO) | – | |
| 06009201 | European Patent Office (EPO) | A | |
| 2007054204 | European Patent Office (EPO) | W |
Members125
| Document | Office | Kind | |
|---|---|---|---|
| EP1852108A1 | European Patent Office (EPO) | A1 | |
| AU2007247193A1 | Australia | A1 | |
| CA2649922A1 | Canada | A1 | |
| WO2007128724A1 | World Intellectual Property Organization (WIPO) | A1 | |
| UY30319A1 | Uruguay | A1 | |
| TW200812648A | Taiwan Province of China | A | |
| US2008107731A1 | United States of America | A1 | |
| AR060755A1 | Argentina | A1 | |
| PE20080698A1 | Peru | A1 | |
| MX2008013958A | Mexico | A | |
| ECSP088800A | Ecuador | A | |
| NO20084256L | Norway | L | |
| KR20090009226A | Republic of Korea | A | |
| EP2023902A1 | European Patent Office (EPO) | A1 | |
| CN101437493A | China | A | |
| EA200802184A1 | Eurasian Patent Organization (EAPO) | A1 | |
| IL195030A0 | Israel | A0 | |
| IL195030D0 | Israel | D0 | |
| JP2009535376A | Japan | A | |
| HK1130442A | Hong Kong, China | A | |
| HK1130442A1 | Hong Kong, China | A1 | |
| EP2023902B1 | European Patent Office (EPO) | B1 | |
| AT480228T | Austria | T | |
| ATE480228T1 | Austria | T1 | |
| PT2023902E | Portugal | E | |
| DE602007009091D1 | Germany | D1 | |
| ZA200808361B | South Africa | B | |
| HRP20100507T1 | Croatia | T1 | |
| DK2023902T3 | Denmark | T3 | |
| EP2023902B8This record | European Patent Office (EPO) | B8 | |
| ES2348576T3 | Spain | T3 | |
| EP2277509A1 | European Patent Office (EPO) | A1 | |
| SI2023902T1 | Slovenia | T1 | |
| EP2283819A1 | European Patent Office (EPO) | A1 | |
| PL2023902T3 | Poland | T3 | |
| RS51466B | Serbia | B | |
| BRPI0711179A2 | Brazil | A2 | |
| UA94942C2 | Ukraine | C2 | |
| SG171649A1 | Singapore | A1 | |
| PL2023902T4 | Poland | T4 | |
| IL212841A0 | Israel | A0 | |
| IL212841D0 | Israel | D0 | |
| PE20110666A1 | Peru | A1 | |
| NZ572862A | New Zealand | A | |
| US2012003313A1 | United States of America | A1 | |
| AR079930A2 | Argentina | A2 | |
| JP2012072187A | Japan | A | |
| EA201100958A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EA016559B1 | Eurasian Patent Organization (EAPO) | B1 | |
| CN102526737A | China | A | |
| US2012219622A1 | United States of America | A1 | |
| MY146969A | Malaysia | A | |
| CL2012002521A1 | Chile | A1 | |
| CL2012002522A1 | Chile | A1 | |
| ME01170B | Montenegro | B | |
| HK1172549A | Hong Kong, China | A | |
| HK1172549A1 | Hong Kong, China | A1 | |
| MY148496A | Malaysia | A | |
| AU2007247193B2 | Australia | B2 | |
| US2013122089A1 | United States of America | A1 | |
| NZ595983A | New Zealand | A | |
| IL195030A | Israel | A | |
| CN101437493B | China | B | |
| JP2013227338A | Japan | A | |
| CA2649922C | Canada | C | |
| JP5478244B2 | Japan | B2 | |
| TW201417844A | Taiwan Province of China | A | |
| KR20140063896A | Republic of Korea | A | |
| EP2283819B1 | European Patent Office (EPO) | B1 | |
| PT2283819E | Portugal | E | |
| DK2283819T3 | Denmark | T3 | |
| KR101478983B1 | Republic of Korea | B1 | |
| ES2527409T3 | Spain | T3 | |
| SI2283819T1 | Slovenia | T1 | |
| CN102526737B | China | B | |
| NZ613426A | New Zealand | A | |
| RS53570B1 | Serbia | B1 | |
| TWI474843B | Taiwan Province of China | B | |
| EP2277509B1 | European Patent Office (EPO) | B1 | |
| EP2283819B9 | European Patent Office (EPO) | B9 | |
| ES2527409T4 | Spain | T4 | |
| HRP20150003T1 | Croatia | T1 | |
| PL2283819T3 | Poland | T3 | |
| DK2277509T3 | Denmark | T3 | |
| BRPI0722388A2 | Brazil | A2 | |
| ME01941B | Montenegro | B | |
| DK2277509T5 | Denmark | T5 | |
| ES2538818T3 | Spain | T3 | |
| PL2277509T3 | Poland | T3 | |
| CY1111354T1 | Cyprus | T1 | |
| EP2910241A1 | European Patent Office (EPO) | A1 | |
| KR20150100957A | Republic of Korea | A | |
| HRP20150003T2 | Croatia | T2 | |
| US2016022687A1 | United States of America | A1 | |
| TWI520753B | Taiwan Province of China | B | |
| HUE025210T2 | Hungary | T2 | |
| JP2016104811A | Japan | A | |
| KR20160128446A | Republic of Korea | A | |
| CY1116064T1 | Cyprus | T1 | |
| KR101710881B1 | Republic of Korea | B1 |
Showing 100 of 125
88 legal events, as 17 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Opt-out of the competence of the unified patent court (upc) registeredCASE NUMBER: UPC_APP_110746/2023P01 | P01 | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Translation of amended ep patentT4 | T4 | PL | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Translation of ep patentT3 | T3 | PL | |
| Translation of european patent specification into slovakT3 | T3 | SK | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Translation of the specification of european patent valid in estoniaFG4A | FG4A | EE | |
| Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3 | T3 | NL | |
| Ep patent valid in romaniaEPE | EPE | RO | |
| Definitive protectionFG2A | FG2A | ES | |
| Ep patent validated in greeceEP | EP | GR | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Ep patent validated in croatiaT1PR | T1PR | HR | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Corresponds to:REF | REF | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Request for ep validation receivedTUEP | TUEP | HR | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2023902
- Application
- 77286581
Titles3
- German
- DPP-IV-INHIBITOR-FORMULIERUNGEN
- English
- DPP IV INHIBITOR FORMULATIONS
- French
- FORMULATIONS DE L'INHIBITEUR DE DPP IV
Classification
- CPC, 31
- A61K31/522
- A61K47/38
- A61K31/519
- A61K9/2009
- A61K9/2054
- A61K9/2059
- A61K9/2077
- A61K9/2866
- A61K31/517
- A61K9/0053
- A61P19/02
- A61P19/10
- A61P29/00
- A61P3/00
- A61P3/10
- A61P3/04
- A61P3/06
- A61P37/06
- A61P43/00
- A61K9/20
- A61K9/48
- A61K9/4866
- A61K9/4891
- A61K47/30
- A61K47/34
- A61K9/2013
- A61K9/28
- A61K9/2027
- A61K9/2813
- A61K9/2853
- A61K9/2893
- IPC, 4
- A61K9 16
- A61K9 32
- A61P3 10
- A61K38 095
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- Serbia